Biopolis S.L.

Pharmatory Ltd. is a Finnish cGMP custom synthesis provider for pharmaceutical companies. Pharmatory specialises in custom process R&D, scale-up and cGMP manufacturing of key intermediates and active pharmaceutical ingredients with focus on quality operation and timely delivery.

We offer following services:
- Custom synthesis and development of APIs and key intermediates
- Process research and development, scale-up and optimization
- cGMP manufacturing (scale from milligrams up to tens of kilograms)
- Biocatalysis services
- Preparation of reference materials
- Preparation of isotope labeled substances
- Stability testing, impurity profiling
- Development and validation of analytical methods

Own products (APIs) for the generic pharmaceutical industry.

We provide quality products and services, consistently,
reliably responsibly and continuously applying some of the world’s
most difficult to handle chemical technologies.
Our independent one-site,
single entity corporate setup enables


Synthesis: Manufacturing services and products for all user industries,
using Archimica´s highly differentiated setup and technologies
APIs, Building blocks, GMP intermediates, Regulatory Starting Materials
For all global markets including the United States of America,
in total Archimica products reach 25 countries.

Aurora Fine Chemicals is a privately held company that was founded in 1990. As a chemicals R&D supplier we offer chemicals for R&D, drug discovery service, compound libraries and custom synthesis. We have one of the largest collections of 18.1 mln. chemicals available in stock and our docking software delivers hits/leads of very high quality in short time.

Our staff consists of highly qualified individuals with Bsc, Msc and Ph.D. degrees in chemistry, as well as excellent laboratory technicians. In our Molecular Modeling Group are professionals specializing in computational drug design. They possess many years experience of working in the chemistry of heterocycles, carbohydrates, nucleosides and elemental organic compounds. Aurora has significant expertise in synthesis of all types R&D chemicals for drug discovery like small molecules, natural products and peptides. Parallel synthesis with well-designed, targeted and fragment-based libraries is the favored approach to lead optimization. Rational design is the strategy for projects driven by structural biology, such as enzyme inhibitors or protein interactions.

We own a large library of 18.1 million stocked compounds for R&D. Our substances are used in many research labs all over the world. We offer structures for biochemical and chemical research. Our products are applied in pharmaceutical development, diagnosis, and in chemical production.

Several laboratories for synthesis with modern equipment such as reactors, autoclaves, thermostats and hydrogenation equipment are available.

Intermediates and final products are analyzed by GC, HPLC, IR, NMR, MS, elemental analysis, atom-absorption analysis and crystallographical methods.

The main advantage of Aurora's own software is the quality of the underlying physical models. Aurora's software derives molecular properties from first principles based on direct models using advanced quantum mechanical analysis of molecular interactions and thermodynamics.

We support life science organisations by solving their research and development problems.

With extensive background in chemical and pharmaceutical industries our team provides consultancy services covering project management, outsourcing, manufacturing and training.

By going beyond the conventional consultancy model and tackling the chemistry challenges directly we divert compound manufacture and supply risks from our clients. Our undertaking to produce the molecules you need frees your time to focus on other discovery and development objectives.

Our individually tailored solutions address key R&D needs including:

Project management;
Filling the resource and skills gap by providing project management

Synthesis and manufacturing;
Synthesising non-commercial compound and fine chemicals
Helping with developing and producing drug candidates to cGMP

Material supply;
Finding hard-to-find commercial fine chemicals and active drugs

Technology solutions;
Identifying enabling technologies that facilitate drug development

Training;
If you wish to use your scientific, technical, or management expertise to work as independent consultants we provide you with the necessary training to set up your business.
Our course provides step-by-step training for people who have extensive scientific or technical background and have worked in the industry, public sector or academia before and now wish to work as independent consultants.
The course is accredited and is approved by the Royal Society of Chemistry for Continuing Professional Development (CPD).

DOTTIKON ES manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical, biotech, and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader. Its safety culture created over the past 105 years guides the innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing in order to challenge, tighten, or shorten conventional chemical synthesis routes, improve selectivities, yields, and purities, and reduce waste.

The versatile technology and equipment portfolio is used, maintained, and continuously expanded to design, develop, and optimize chemical processes and technical manufacturing procedures for the rapid scale-up from kilograms to multi-tons in order to produce and deliver the respective market volumes.

DOTTIKON ES' one-site strategy allows reduced decision and communication pathways. This ensures rapid and efficient project development, clear and transparent data and process documentation, and close customer communication.